Lenalidomide in HTLV-1 Adult T-Cell Leukemia

NCT01274533 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Adult T Cell Leukemia/Lymphoma

Interventions

DRUG: Lenalidomide

Sponsor

Columbia University

Collaborators

[object Object]